查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1449254

全球口腔黏膜藥物市場：份額、規模、趨勢、行業分析報告 - 按產品類型、給藥途徑、適應症、分銷管道、地區和細分市場預測，2024-2032 年

Oral Transmucosal Drugs Market Share, Size, Trends, Industry Analysis Report, By Product Type (Tablets, Films), By Route of Administration, By Indication, By Distribution Channel, By Region, And Segment Forecasts, 2024 - 2032
出版日期: | 出版商: Polaris Market Research | 英文 115 Pages | 商品交期: 最快1-2個工作天內

價格

預計2032年，全球口腔黏膜藥物市場規模將達到829.9億美元。 該報告提供了對當前市場動態的詳細見解，並對未來市場成長進行了分析。

研發工作的激增，加上新產品的推出和目標疾病盛行率的增加，必將推動市場成長。 此外，目標人群的增加預計將有助於市場擴張。 口服經黏膜芬太尼檸檬酸鹽的獨特配方將芬太尼融入含片中，通過頰黏膜輸送藥物，與口服途徑相比，通過繞過首過代謝提高了生物利用度。

因此，尋求立即緩解各種疾病相關疼痛的患者群體對阿片類藥物的依賴性不斷增加，可能會推動對口腔黏膜藥物的需求。 例如，根據世界衛生組織 2021 年的數據，全球約有 2.75 億人使用毒品，其中約 6,200 萬人使用鴉片類藥物。

帕金森氏症 (PD) 和偏頭痛盛行率的增加預計將推動市場擴張。 例如，根據帕金森氏症基金會2022年1月發布的數據，美國目前約有1,000萬人患有帕金森氏症，預計到2030年將增加至約120萬人。 帕金森氏症是繼阿茲海默症之後第二常見的神經退化性疾病，每年有超過 60,000 名美國人被診斷出患有帕金森氏症。 此類疾病的日益普及可能會推動使用口腔黏膜藥物進行治療，從而改善疼痛管理並立即緩解疼痛。

根據CDC 數據，截至2021 年1 月，美國65 歲及以上的成年人中有26% 擁有八顆或更少的牙齒，而同年齡層的成年人中約有六分之一(17 %) 的牙齒已全部失去。他的牙齒。 此外，根據 2022 年 2 月 CDC 數據，美國 18 歲以上成年人中有 63% 在過去一年看過牙醫，2020 年 2 至 17 歲兒童中有 85.9% 曾看過牙醫。考試。 牙科就診次數的增加預計將推動對用於鎮靜和鎮痛的口腔黏膜藥物（例如咪達唑侖和丁丙諾啡）的需求。

口腔黏膜藥物市場報告重點

片劑由於易於使用、易於吸收、效率高而佔據最大的市場份額

阿片類藥物成癮正在佔領市場，這主要是由於阿片類藥物疾病的增加。

舌下含服藥是治療急性疼痛的首選，市佔率最大

由於亞太地區大量人口遭受壓力和精神問題，預計該地區將以最快的速度增長。

市場參與者包括 Aquestive Therapeutics、C.L. Pharm、GW Pharmaceuticals、IntelGenx、輝瑞、Seoul Pharmaceuticals 和 Shilpa Therapeutics。

目錄

第1章簡介

第 2 章執行摘要

第3章研究方法

第4章全球口腔黏膜藥物市場洞察

  • 口腔黏膜藥物 - 產業概況
  • 口腔黏膜藥物市場動態
    • 推動者和機會
      • 越來越多地在醫療保健領域使用口腔黏膜藥物技術
      • 技術進步
    • 抑制因素和挑戰
      • 日益數位化限制了市場成長
  • 杵分析
  • 口腔黏膜藥物產業的趨勢
  • 價值鏈分析
  • COVID-19 感染的影響分析

第5章全球口腔黏膜藥物市場：依產品類型

  • 主要發現
  • 簡介
  • 平板電腦
  • 電影
  • 液體/噴霧
  • 其他

第6章全球口腔黏膜藥物市場：依給藥途徑劃分

  • 主要發現
  • 簡介
  • 舌下黏膜
  • 其他

第7章全球口腔黏膜藥物市場：依適應症劃分

  • 主要發現
  • 簡介
  • 阿片類藥物依賴
  • 噁心和嘔吐
  • 勃起功能障礙
  • 神經系統疾病
  • 其他

第 8 章全球口腔黏膜藥物市場：依通路劃分

  • 主要發現
  • 簡介
  • 醫院藥房
  • 零售藥局
  • 網路藥局

第 9 章全球口腔黏膜藥物市場：按地區

  • 主要發現
  • 簡介
    • 口腔黏膜藥物市場評估：按地區（2019-2032）
  • 口腔黏膜藥物市場 - 北美
    • 依產品類型劃分（2019-2032）
    • 依通路劃分（2019-2032）
    • 依給藥途徑（2019-2032）
    • 依指示（2019-2032）
    • 美國
    • 加拿大
  • 口腔黏膜藥物市場 - 歐洲
    • 依產品類型劃分（2019-2032）
    • 依通路劃分（2019-2032）
    • 依給藥途徑（2019-2032）
    • 依指示（2019-2032）
    • 英國
    • 法國
    • 德國
    • 義大利
    • 西班牙
    • 荷蘭
    • 俄羅斯
  • 口腔黏膜藥物市場 - 亞太地區
    • 依產品類型劃分（2019-2032）
    • 依通路劃分（2019-2032）
    • 依給藥途徑（2019-2032）
    • 依指示（2019-2032）
    • 中國
    • 印度
    • 日本
    • 馬來西亞
    • 印尼
    • 韓國
  • 口腔黏膜藥物市場 - 中東和非洲
    • 依產品類型劃分（2019-2032）
    • 依通路劃分（2019-2032）
    • 依給藥途徑（2019-2032）
    • 依指示（2019-2032）
    • 沙烏地阿拉伯
    • 南非
    • 以色列
    • 阿拉伯聯合大公國
  • 口腔黏膜藥物市場 - 拉丁美洲
    • 依產品類型劃分（2019-2032）
    • 依通路劃分（2019-2032）
    • 依給藥途徑（2019-2032）
    • 依指示（2019-2032）
    • 墨西哥
    • 巴西
    • 阿根廷

第10章競爭態勢

  • 擴張與收購分析
    • 放大
    • 收購
  • 夥伴關係/協作/協議/揭露

第11章公司簡介

  • Aquestive Therapeutics, Inc
  • C.L.Pharm Co., Ltd
  • GW Pharmaceuticals plc
  • IntelGenx Corp
  • IntelGenx Corp
  • Pfizer Inc
  • Seoul Pharmaceuticals
  • Shilpa Therapeutics
  • Sunovion Pharmaceuticals, Inc.
  • ZIM Laboratories Limited
Product Code: PM4439

The global oral transmucosal drugs market size is expected to reach USD 82.99 billion by 2032, according to a new study by Polaris Market Research. The report "Oral Transmucosal Drugs Market Share, Size, Trends, Industry Analysis Report, By Product Type (Tablets, Films), By Route of Administration, By Indication, By Distribution Channel, By Region, And Segment Forecasts, 2024 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The surge in research and development endeavors, coupled with new product launches and an increase in the prevalence of targeted diseases, is poised to propel market growth. Additionally, the growth in the target population is expected to contribute to the market's expansion. The unique formulation of oral transmucosal fentanyl citrate, incorporating fentanyl in a lozenge for drug delivery through the buccal mucosa, offers enhanced bioavailability compared to the oral route by bypassing first-pass metabolism.

Consequently, the growing opioid dependence within the patient population seeking immediate relief from pain associated with various disorders is likely to drive the demand for oral transmucosal drugs, for example, as per the World Health Organization's data from 2021, around 275 million people globally used medications, with approximately 62 million among them using opioids.

The growing prevalence of Parkinson's disease (PD) and migraine is anticipated to drive the expansion of the market. For instance, data from the Parkinson's Foundation, January 2022, reveals that nearly one million people in the United States are currently living with Parkinson's disease, with projections indicating an increase to around 1.2 Mn by 2030. Parkinson's disease stands as the second-most common neurodegenerative disease, following Alzheimer's disease, with over 60,000 Americans diagnosed annually and a global population exceeding 10 Mn individuals living with PD. The rising incidences of such disorders are likely to boost the adoption of oral transmucosal drugs for their treatment, leading to improved pain management and immediate relief.

As of January 2021, data from the CDC indicates that 26% of adults aged 65 or older had eight or fewer teeth, and approximately 1 in 6 (17%) adults in the same age group had lost all their teeth in the United States. Additionally, according to CDC data from February 2022, 63% of adults aged 18 and over in the United States had a dental visit in the past year, and 85.9% of children aged 2-17 years had a dental visit in the year 2020. This rise in dental visits is expected to fuel the demand for oral transmucosal drugs, such as midazolam and buprenorphine, for sedation and pain relief.

Oral Transmucosal Drugs Market Report Highlights

Tablets segment held the largest share, owing to its ease of use, easy absorption, and have higher efficiency

Opioid dependence segment dominated the market, primarily due to rising cases of opioid disorders

Sub-lingual drugs garnered the largest share, as they are mostly preferred during acute pain conditions

APAC expected to grow at the fastest rate, due to presence of huge population suffering with stress and mental conditions

The market players include Aquestive Therapeutics, C.L. Pharm, GW Pharmaceuticals, IntelGenx, Pfizer, Seoul Pharmaceuticals, and Shilpa Therapeutics

Polaris Market Research has segmented the oral transmucosal drugs market report based on product type, route of administration, indication, distribution channel, and region:

Oral Transmucosal Drugs, Product Type Outlook (Revenue - USD Billion, 2019 - 2032)

  • Tablets
  • Films
  • Liquid & Spray
  • Others

Oral Transmucosal Drugs, Route of Administration Outlook (Revenue - USD Billion, 2019 - 2032)

  • Sublingual Mucosa
  • Buccal Mucosa
  • Others

Oral Transmucosal Drugs, Indication Outlook (Revenue - USD Billion, 2019 - 2032)

  • Opioid Dependence
  • Nausea and Vomiting
  • Erectile Dysfunction
  • Neurological Disorders
  • Others

Oral Transmucosal Drugs, Distribution Channel Outlook (Revenue - USD Billion, 2019 - 2032)

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Oral Transmucosal Drugs, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa

Table of Contents

1.Introduction

  • 1.1.Report Description
    • 1.1.1.Objectives of the Study
    • 1.1.2.Market Scope
    • 1.1.3.Assumptions
  • 1.2.Stakeholders

2.Executive Summary

  • 2.1.Market Highlights

3.Research Methodology

  • 3.1.Overview
    • 3.1.1.Data Mining
  • 3.2.Data Sources
    • 3.2.1.Primary Sources
    • 3.2.2.Secondary Sources

4.Global Oral Transmucosal Drugs Market Insights

  • 4.1.Oral Transmucosal Drugs - Industry Snapshot
  • 4.2.Oral Transmucosal Drugs Market Dynamics
    • 4.2.1.Drivers and Opportunities
      • 4.2.1.1.Increasing use of Oral Transmucosal Drugs technology in healthcare
      • 4.2.1.2.Technological advancement
    • 4.2.2.Restraints and Challenges
      • 4.2.2.1.Increasing digitization will restrict the market growth
  • 4.3.Porter's Five Forces Analysis
    • 4.3.1.Bargaining Power of Suppliers (Moderate)
    • 4.3.2.Threats of New Entrants: (Low)
    • 4.3.3.Bargaining Power of Buyers (Moderate)
    • 4.3.4.Threat of Substitute (Moderate)
    • 4.3.5.Rivalry among existing firms (High)
  • 4.4.PESTLE Analysis
  • 4.5.Oral Transmucosal Drugs Industry Trends
  • 4.6.Value Chain Analysis
  • 4.7.COVID-19 Impact Analysis

5.Global Oral Transmucosal Drugs Market, by Product Distribution Channel

  • 5.1.Key Findings
  • 5.2.Introduction
    • 5.2.1.Global Oral Transmucosal Drugs Market, by Product Distribution Channel, 2019-2032 (USD Billion)
  • 5.3.Tablets
    • 5.3.1.Global Oral Transmucosal Drugs Market, by Tablets, by Region, 2019-2032 (USD Billion)
  • 5.4.Films
    • 5.4.1.Global Oral Transmucosal Drugs Market, by Films, by Region, 2019-2032 (USD Billion)
  • 5.5.Liquid & Spray
    • 5.5.1.Global Oral Transmucosal Drugs Market, by Liquid & Spray, by Region, 2019-2032 (USD Billion)
  • 5.6.Others
    • 5.6.1.Global Oral Transmucosal Drugs Market, by Others , by Region, 2019-2032 (USD Billion)

6.Global Oral Transmucosal Drugs Market, by Route of Administration

  • 6.1.Key Findings
  • 6.2.Introduction
    • 6.2.1.Global Oral Transmucosal Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • 6.3.Sublingual Mucosa
    • 6.3.1.Global Oral Transmucosal Drugs Market, by Sublingual Mucosa, by Region, 2019-2032 (USD Billion)
  • 6.4.Sublingual Mucosa
    • 6.4.1.Global Oral Transmucosal Drugs Market, by Sublingual Mucosa, by Region, 2019-2032 (USD Billion)
  • 6.5.Others
    • 6.5.1.Global Oral Transmucosal Drugs Market, by Others, by Region, 2019-2032 (USD Billion)

7.Global Oral Transmucosal Drugs Market, by Indication

  • 7.1.Key Findings
  • 7.2.Introduction
    • 7.2.1.Global Oral Transmucosal Drugs Market, by Indication, 2019-2032 (USD Billion)
  • 7.3.Opioid Dependence
    • 7.3.1.Global Oral Transmucosal Drugs Market, by Opioid Dependence, by Region, 2019-2032 (USD Billion)
  • 7.4.Nausea and Vomiting
    • 7.4.1.Global Oral Transmucosal Drugs Market, by Nausea and Vomiting, by Region, 2019-2032 (USD Billion)
  • 7.5.Erectile Dysfunction
    • 7.5.1.Global Oral Transmucosal Drugs Market, by Erectile Dysfunction, by Region, 2019-2032 (USD Billion)
  • 7.6.Neurological Disorders
    • 7.6.1.Global Oral Transmucosal Drugs Market, by Neurological Disorders, by Region, 2019-2032 (USD Billion)
  • 7.7.Others
    • 7.7.1.Global Oral Transmucosal Drugs Market, by Others, by Region, 2019-2032 (USD Billion)

8.Global Oral Transmucosal Drugs Market, by Distribution Channel

  • 8.1.Key Findings
  • 8.2.Introduction
    • 8.2.1.Global Oral Transmucosal Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • 8.3.Hospital Pharmacies
    • 8.3.1.Global Oral Transmucosal Drugs Market, by Hospital Pharmacies, by Region, 2019-2032 (USD Billion)
  • 8.4.Retail Pharmacies
    • 8.4.1.Global Oral Transmucosal Drugs Market, by Retail Pharmacies, by Region, 2019-2032 (USD Billion)
  • 8.5.Online Pharmacies
    • 8.5.1.Global Oral Transmucosal Drugs Market, by Online Pharmacies, by Region, 2019-2032 (USD Billion)

9.Global Oral Transmucosal Drugs Market, by Geography

  • 9.1.Key findings
  • 9.2.Introduction
    • 9.2.1.Oral Transmucosal Drugs Market Assessment, By Geography, 2019-2032 (USD Billion)
  • 9.3.Oral Transmucosal Drugs Market - North America
    • 9.3.1.North America: Oral Transmucosal Drugs Market, by Product Distribution Channel, 2019-2032 (USD Billion)
    • 9.3.2.North America: Oral Transmucosal Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 9.3.3.North America: Oral Transmucosal Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    • 9.3.4.North America: Oral Transmucosal Drugs Market, by Indication, 2019-2032 (USD Billion)
    • 9.3.5.Oral Transmucosal Drugs Market - U.S.
      • 9.3.5.1.U.S.: Oral Transmucosal Drugs Market, by Product Distribution Channel, 2019-2032 (USD Billion)
      • 9.3.5.2.U.S.: Oral Transmucosal Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 9.3.5.3.U.S.: Oral Transmucosal Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
      • 9.3.5.4.U.S.: Oral Transmucosal Drugs Market, by Indication, 2019-2032 (USD Billion)
    • 9.3.6.Oral Transmucosal Drugs Market - Canada
      • 9.3.6.1.Canada: Oral Transmucosal Drugs Market, by Product Distribution Channel, 2019-2032 (USD Billion)
      • 9.3.6.2.Canada: Oral Transmucosal Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 9.3.6.3.Canada: Oral Transmucosal Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
      • 9.3.6.4.Canada: Oral Transmucosal Drugs Market, by Indication, 2019-2032 (USD Billion)
  • 9.4.Oral Transmucosal Drugs Market - Europe
    • 9.4.1.Europe: Oral Transmucosal Drugs Market, by Product Distribution Channel, 2019-2032 (USD Billion)
    • 9.4.2.Europe: Oral Transmucosal Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 9.4.3.Europe: Oral Transmucosal Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    • 9.4.4.Europe: Oral Transmucosal Drugs Market, by Indication, 2019-2032 (USD Billion)
    • 9.4.5.Oral Transmucosal Drugs Market - UK
      • 9.4.5.1.UK: Oral Transmucosal Drugs Market, by Product Distribution Channel, 2019-2032 (USD Billion)
      • 9.4.5.2.UK: Oral Transmucosal Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 9.4.5.3.UK: Oral Transmucosal Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
      • 9.4.5.4.UK: Oral Transmucosal Drugs Market, by Indication, 2019-2032 (USD Billion)
    • 9.4.6.Oral Transmucosal Drugs Market - France
      • 9.4.6.1.France: Oral Transmucosal Drugs Market, by Product Distribution Channel, 2019-2032 (USD Billion)
      • 9.4.6.2.France: Oral Transmucosal Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 9.4.6.3.France: Oral Transmucosal Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
      • 9.4.6.4.France: Oral Transmucosal Drugs Market, by Indication, 2019-2032 (USD Billion)
    • 9.4.7.Oral Transmucosal Drugs Market - Germany
      • 9.4.7.1.Germany: Oral Transmucosal Drugs Market, by Product Distribution Channel, 2019-2032 (USD Billion)
      • 9.4.7.2.Germany: Oral Transmucosal Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 9.4.7.3.Germany: Oral Transmucosal Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
      • 9.4.7.4.Germany: Oral Transmucosal Drugs Market, by Indication, 2019-2032 (USD Billion)
    • 9.4.8.Oral Transmucosal Drugs Market - Italy
      • 9.4.8.1.Italy: Oral Transmucosal Drugs Market, by Product Distribution Channel, 2019-2032 (USD Billion)
      • 9.4.8.2.Italy: Oral Transmucosal Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 9.4.8.3.Italy: Oral Transmucosal Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
      • 9.4.8.4.Italy: Oral Transmucosal Drugs Market, by Indication, 2019-2032 (USD Billion)
    • 9.4.9.Oral Transmucosal Drugs Market - Spain
      • 9.4.9.1.Spain: Oral Transmucosal Drugs Market, by Product Distribution Channel, 2019-2032 (USD Billion)
      • 9.4.9.2.Spain: Oral Transmucosal Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 9.4.9.3.Spain: Oral Transmucosal Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
      • 9.4.9.4.Spain: Oral Transmucosal Drugs Market, by Indication, 2019-2032 (USD Billion)
    • 9.4.10.Oral Transmucosal Drugs Market - Netherlands
      • 9.4.10.1.Netherlands: Oral Transmucosal Drugs Market, by Product Distribution Channel, 2019-2032 (USD Billion)
      • 9.4.10.2.Netherlands: Oral Transmucosal Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 9.4.10.3.Netherlands: Oral Transmucosal Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
      • 9.4.10.4.Netherlands: Oral Transmucosal Drugs Market, by Indication, 2019-2032 (USD Billion)
    • 9.4.11.Oral Transmucosal Drugs Market - Russia
      • 9.4.11.1.Russia: Oral Transmucosal Drugs Market, by Product Distribution Channel, 2019-2032 (USD Billion)
      • 9.4.11.2.Russia.: Oral Transmucosal Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 9.4.11.3.Russia: Oral Transmucosal Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
      • 9.4.11.4.Russia: Oral Transmucosal Drugs Market, by Indication, 2019-2032 (USD Billion)
  • 9.5.Oral Transmucosal Drugs Market - Asia Pacific
    • 9.5.1.Asia Pacific: Oral Transmucosal Drugs Market, by Product Distribution Channel, 2019-2032 (USD Billion)
    • 9.5.2.Asia Pacific: Oral Transmucosal Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 9.5.3.Asia Pacific: Oral Transmucosal Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    • 9.5.4.Asia Pacific: Oral Transmucosal Drugs Market, by Indication, 2019-2032 (USD Billion)
    • 9.5.5.Oral Transmucosal Drugs Market - China
      • 9.5.5.1.China: Oral Transmucosal Drugs Market, by Product Distribution Channel, 2019-2032 (USD Billion)
      • 9.5.5.2.China.: Oral Transmucosal Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 9.5.5.3.China: Oral Transmucosal Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
      • 9.5.5.4.China: Oral Transmucosal Drugs Market, by Indication, 2019-2032 (USD Billion)
    • 9.5.6.Oral Transmucosal Drugs Market - India
      • 9.5.6.1.India: Oral Transmucosal Drugs Market, by Product Distribution Channel, 2019-2032 (USD Billion)
      • 9.5.6.2.India.: Oral Transmucosal Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 9.5.6.3.India: Oral Transmucosal Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
      • 9.5.6.4.India: Oral Transmucosal Drugs Market, by Indication, 2019-2032 (USD Billion)
    • 9.5.7.Oral Transmucosal Drugs Market - Japan
      • 9.5.7.1.Japan: Oral Transmucosal Drugs Market, by Product Distribution Channel, 2019-2032 (USD Billion)
      • 9.5.7.2.Japan.: Oral Transmucosal Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 9.5.7.3.Japan: Oral Transmucosal Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
      • 9.5.7.4.Japan: Oral Transmucosal Drugs Market, by Indication, 2019-2032 (USD Billion)
    • 9.5.8.Oral Transmucosal Drugs Market - Malaysia
      • 9.5.8.1.Malaysia: Oral Transmucosal Drugs Market, by Product Distribution Channel, 2019-2032 (USD Billion)
      • 9.5.8.2.Malaysia.: Oral Transmucosal Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 9.5.8.3.Malaysia: Oral Transmucosal Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
      • 9.5.8.4.Malaysia: Oral Transmucosal Drugs Market, by Indication, 2019-2032 (USD Billion)
    • 9.5.9.Oral Transmucosal Drugs Market - Indonesia
      • 9.5.9.1.Indonesia: Oral Transmucosal Drugs Market, by Product Distribution Channel, 2019-2032 (USD Billion)
      • 9.5.9.2.Indonesia.: Oral Transmucosal Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 9.5.9.3.Indonesia: Oral Transmucosal Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
      • 9.5.9.4.Indonesia: Oral Transmucosal Drugs Market, by Indication, 2019-2032 (USD Billion)
    • 9.5.10.Oral Transmucosal Drugs Market - South Korea
      • 9.5.10.1.South Korea: Oral Transmucosal Drugs Market, by Product Distribution Channel, 2019-2032 (USD Billion)
      • 9.5.10.2.South Korea.: Oral Transmucosal Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 9.5.10.3.South Korea: Oral Transmucosal Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
      • 9.5.10.4.South Korea: Oral Transmucosal Drugs Market, by Indication, 2019-2032 (USD Billion)
  • 9.6.Oral Transmucosal Drugs Market - Middle East & Africa
    • 9.6.1.Middle East & Africa: Oral Transmucosal Drugs Market, by Product Distribution Channel, 2019-2032 (USD Billion)
    • 9.6.2.Middle East & Africa: Oral Transmucosal Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 9.6.3.Middle East & Africa: Oral Transmucosal Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    • 9.6.4.Middle East & Africa: Oral Transmucosal Drugs Market, by Indication, 2019-2032 (USD Billion)
    • 9.6.5.Oral Transmucosal Drugs Market - Saudi Arabia
      • 9.6.5.1.Saudi Arabia: Oral Transmucosal Drugs Market, by Product Distribution Channel, 2019-2032 (USD Billion)
      • 9.6.5.2.Saudi Arabia: Oral Transmucosal Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 9.6.5.3.Saudi Arabia: Oral Transmucosal Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
      • 9.6.5.4.Saudi Arabia: Oral Transmucosal Drugs Market, by Indication, 2019-2032 (USD Billion)
    • 9.6.6.Oral Transmucosal Drugs Market - South Africa
      • 9.6.6.1.South Africa: Oral Transmucosal Drugs Market, by Product Distribution Channel, 2019-2032 (USD Billion)
      • 9.6.6.2.South Africa: Oral Transmucosal Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 9.6.6.3.South Africa: Oral Transmucosal Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
      • 9.6.6.4.South Africa: Oral Transmucosal Drugs Market, by Indication, 2019-2032 (USD Billion)
    • 9.6.7.Oral Transmucosal Drugs Market - Israel
      • 9.6.7.1.Israel: Oral Transmucosal Drugs Market, by Product Distribution Channel, 2019-2032 (USD Billion)
      • 9.6.7.2.Israel: Oral Transmucosal Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 9.6.7.3.Israel: Oral Transmucosal Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
      • 9.6.7.4.Israel: Oral Transmucosal Drugs Market, by Indication, 2019-2032 (USD Billion)
    • 9.6.8.Oral Transmucosal Drugs Market - UAE
      • 9.6.8.1.UAE: Oral Transmucosal Drugs Market, by Product Distribution Channel, 2019-2032 (USD Billion)
      • 9.6.8.2.UAE: Oral Transmucosal Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 9.6.8.3.UAE: Oral Transmucosal Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
      • 9.6.8.4.UAE: Oral Transmucosal Drugs Market, by Indication, 2019-2032 (USD Billion)
  • 9.7.Oral Transmucosal Drugs Market - Latin America
    • 9.7.1.Latin America: Oral Transmucosal Drugs Market, by Product Distribution Channel, 2019-2032 (USD Billion)
    • 9.7.2.Latin America: Oral Transmucosal Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 9.7.3.Latin America: Oral Transmucosal Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    • 9.7.4.Latin America: Oral Transmucosal Drugs Market, by Indication, 2019-2032 (USD Billion)
    • 9.7.5.Oral Transmucosal Drugs Market - Mexico
      • 9.7.5.1.Mexico: Oral Transmucosal Drugs Market, by Product Distribution Channel, 2019-2032 (USD Billion)
      • 9.7.5.2.Mexico: Oral Transmucosal Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 9.7.5.3.Mexico: Oral Transmucosal Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
      • 9.7.5.4.Mexico: Oral Transmucosal Drugs Market, by Indication, 2019-2032 (USD Billion)
    • 9.7.6.Oral Transmucosal Drugs Market - Brazil
      • 9.7.6.1.Brazil: Oral Transmucosal Drugs Market, by Product Distribution Channel, 2019-2032 (USD Billion)
      • 9.7.6.2.Brazil: Oral Transmucosal Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 9.7.6.3.Brazil: Oral Transmucosal Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
      • 9.7.6.4.Brazil: Oral Transmucosal Drugs Market, by Indication, 2019-2032 (USD Billion)
    • 9.7.7.Oral Transmucosal Drugs Market - Argentina
      • 9.7.7.1.Argentina: Oral Transmucosal Drugs Market, by Product Distribution Channel, 2019-2032 (USD Billion)
      • 9.7.7.2.Argentina: Oral Transmucosal Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 9.7.7.3.Argentina: Oral Transmucosal Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
      • 9.7.7.4.Argentina: Oral Transmucosal Drugs Market, by Indication, 2019-2032 (USD Billion)

10.Competitive Landscape

  • 10.1.Expansion and Acquisition Analysis
    • 10.1.1.Expansion
    • 10.1.2.Acquisitions
  • 10.2.Partnerships/Collaborations/Agreements/Exhibitions

11.Company Profiles

  • 11.1.Aquestive Therapeutics, Inc
    • 11.1.1.Company Overview
    • 11.1.2.Financial Performance
    • 11.1.3.Product Benchmarking
    • 11.1.4.Recent Development
  • 11.2.C.L.Pharm Co., Ltd
    • 11.2.1.Company Overview
    • 11.2.2.Financial Performance
    • 11.2.3.Product Benchmarking
    • 11.2.4.Recent Development
  • 11.3.GW Pharmaceuticals plc
    • 11.3.1.Company Overview
    • 11.3.2.Financial Performance
    • 11.3.3.Product Benchmarking
    • 11.3.4.Recent Development
  • 11.4.IntelGenx Corp
    • 11.4.1.Company Overview
    • 11.4.2.Financial Performance
    • 11.4.3.Product Benchmarking
    • 11.4.4.Recent Development
  • 11.5.IntelGenx Corp
    • 11.5.1.Company Overview
    • 11.5.2.Financial Performance
    • 11.5.3.Product Benchmarking
    • 11.5.4.Recent Development
  • 11.6.Pfizer Inc
    • 11.6.1.Company Overview
    • 11.6.2.Financial Performance
    • 11.6.3.Product Benchmarking
    • 11.6.4.Recent Development
  • 11.7.Seoul Pharmaceuticals
    • 11.7.1.Company Overview
    • 11.7.2.Financial Performance
    • 11.7.3.Product Benchmarking
    • 11.7.4.Recent Development
  • 11.8.Shilpa Therapeutics
    • 11.8.1.Company Overview
    • 11.8.2.Financial Performance
    • 11.8.3.Product Benchmarking
    • 11.8.4.Recent Development
  • 11.9.Sunovion Pharmaceuticals, Inc.
    • 11.9.1.Company Overview
    • 11.9.2.Financial Performance
    • 11.9.3.Product Benchmarking
    • 11.9.4.Recent Development
  • 11.10.ZIM Laboratories Limited
    • 11.10.1.Company Overview
    • 11.10.2.Financial Performance
    • 11.10.3.Product Benchmarking
    • 11.10.4.Recent Development

List of Tables

  • Table 1 Global Oral Transmucosal Drugs Market, by Product Distribution Channel, by Region, 2019-2032 (USD Billion)
  • Table 2 Global Oral Transmucosal Drugs Market, by Route of Administration, by Region, 2019-2032 (USD Billion)
  • Table 3 Global Oral Transmucosal Drugs Market, by Indication, by Region, 2019-2032 (USD Billion)
  • Table 4 Global Oral Transmucosal Drugs Market, by Distribution Channel, by Region, 2019-2032 (USD Billion)
  • Table 5 Oral Transmucosal Drugs Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Table 6 North America: Oral Transmucosal Drugs Market, by Product Distribution Channel, 2019-2032 (USD Billion)
  • Table 7 North America: Oral Transmucosal Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 8 North America: Oral Transmucosal Drugs Market, by Indication, 2019-2032 (USD Billion)
  • Table 9 North America: Oral Transmucosal Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 10 U.S.: Oral Transmucosal Drugs Market, by Product Distribution Channel, 2019-2032 (USD Billion)
  • Table 11 U.S.: Oral Transmucosal Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 12 U.S.: Oral Transmucosal Drugs Market, by Indication, 2019-2032 (USD Billion)
  • Table 13 U.S.: Oral Transmucosal Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 14 Canada: Oral Transmucosal Drugs Market, by Product Distribution Channel, 2019-2032 (USD Billion)
  • Table 15 Canada: Oral Transmucosal Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 16 Canada: Oral Transmucosal Drugs Market, by Indication, 2019-2032 (USD Billion)
  • Table 17 Canada: Oral Transmucosal Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 18 Europe: Oral Transmucosal Drugs Market, by Product Distribution Channel, 2019-2032 (USD Billion)
  • Table 19 Europe: Oral Transmucosal Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 20 Europe: Oral Transmucosal Drugs Market, by Indication, 2019-2032 (USD Billion)
  • Table 21 Europe: Oral Transmucosal Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 22 Germany: Oral Transmucosal Drugs Market, by Product Distribution Channel, 2019-2032 (USD Billion)
  • Table 23 Germany: Oral Transmucosal Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 24 Germany: Oral Transmucosal Drugs Market, by Indication, 2019-2032 (USD Billion)
  • Table 25 Germany: Oral Transmucosal Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 26 France: Oral Transmucosal Drugs Market, by Product Distribution Channel, 2019-2032 (USD Billion)
  • Table 27 France: Oral Transmucosal Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 28 France: Oral Transmucosal Drugs Market, by Indication, 2019-2032 (USD Billion)
  • Table 29 France: Oral Transmucosal Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 30 UK: Oral Transmucosal Drugs Market, by Product Distribution Channel, 2019-2032 (USD Billion)
  • Table 31 UK: Oral Transmucosal Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 32 UK: Oral Transmucosal Drugs Market, by Indication, 2019-2032 (USD Billion)
  • Table 33 UK: Oral Transmucosal Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 34 Italy: Oral Transmucosal Drugs Market, by Product Distribution Channel, 2019-2032 (USD Billion)
  • Table 35 Italy: Oral Transmucosal Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 36 Italy: Oral Transmucosal Drugs Market, by Indication, 2019-2032 (USD Billion)
  • Table 37 Italy: Oral Transmucosal Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 38 Netherlands: Oral Transmucosal Drugs Market, by Product Distribution Channel, 2019-2032 (USD Billion)
  • Table 39 Netherlands: Oral Transmucosal Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 40 Netherlands: Oral Transmucosal Drugs Market, by Indication, 2019-2032 (USD Billion)
  • Table 41 Netherlands: Oral Transmucosal Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 42 Spain: Oral Transmucosal Drugs Market, by Product Distribution Channel, 2019-2032 (USD Billion)
  • Table 43 Spain: Oral Transmucosal Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 44 Spain: Oral Transmucosal Drugs Market, by Indication, 2019-2032 (USD Billion)
  • Table 45 Spain: Oral Transmucosal Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 46 Russia: Oral Transmucosal Drugs Market, by Product Distribution Channel, 2019-2032 (USD Billion)
  • Table 47 Russia: Oral Transmucosal Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 48 Russia: Oral Transmucosal Drugs Market, by Indication, 2019-2032 (USD Billion)
  • Table 49 Russia: Oral Transmucosal Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 50 Asia Pacific: Oral Transmucosal Drugs Market, by Product Distribution Channel, 2019-2032 (USD Billion)
  • Table 51 Asia Pacific: Oral Transmucosal Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 52 Asia Pacific: Oral Transmucosal Drugs Market, by Indication, 2019-2032 (USD Billion)
  • Table 53 Asia Pacific: Oral Transmucosal Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 54 China: Oral Transmucosal Drugs Market, by Product Distribution Channel, 2019-2032 (USD Billion)
  • Table 55 China: Oral Transmucosal Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 56 China: Oral Transmucosal Drugs Market, by Indication, 2019-2032 (USD Billion)
  • Table 57 China: Oral Transmucosal Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 58 Japan: Oral Transmucosal Drugs Market, by Product Distribution Channel, 2019-2032 (USD Billion)
  • Table 59 Japan: Oral Transmucosal Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 60 Japan: Oral Transmucosal Drugs Market, by Indication, 2019-2032 (USD Billion)
  • Table 61 Japan: Oral Transmucosal Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 62 India: Oral Transmucosal Drugs Market, by Product Distribution Channel, 2019-2032 (USD Billion)
  • Table 63 India: Oral Transmucosal Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 64 India: Oral Transmucosal Drugs Market, by Indication, 2019-2032 (USD Billion)
  • Table 65 India: Oral Transmucosal Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 66 Indonesia: Oral Transmucosal Drugs Market, by Product Distribution Channel, 2019-2032 (USD Billion)
  • Table 67 Indonesia: Oral Transmucosal Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 68 Indonesia: Oral Transmucosal Drugs Market, by Indication, 2019-2032 (USD Billion)
  • Table 69 Indonesia: Oral Transmucosal Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 70 Malaysia: Oral Transmucosal Drugs Market, by Product Distribution Channel, 2019-2032 (USD Billion)
  • Table 71 Malaysia: Oral Transmucosal Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 72 Malaysia: Oral Transmucosal Drugs Market, by Indication, 2019-2032 (USD Billion)
  • Table 73 Malaysia: Oral Transmucosal Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 74 South Korea: Oral Transmucosal Drugs Market, by Product Distribution Channel, 2019-2032 (USD Billion)
  • Table 75 South Korea: Oral Transmucosal Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 76 South Korea: Oral Transmucosal Drugs Market, by Indication, 2019-2032 (USD Billion)
  • Table 77 South Korea: Oral Transmucosal Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 78 Latin America: Oral Transmucosal Drugs Market, by Product Distribution Channel, 2019-2032 (USD Billion)
  • Table 79 Latin America: Oral Transmucosal Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 80 Latin America: Oral Transmucosal Drugs Market, by Indication, 2019-2032 (USD Billion)
  • Table 81 Latin America: Oral Transmucosal Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 82 Brazil: Oral Transmucosal Drugs Market, by Product Distribution Channel, 2019-2032 (USD Billion)
  • Table 83 Brazil: Oral Transmucosal Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 84 Brazil: Oral Transmucosal Drugs Market, by Indication, 2019-2032 (USD Billion)
  • Table 85 Brazil: Oral Transmucosal Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 86 Mexico: Oral Transmucosal Drugs Market, by Product Distribution Channel, 2019-2032 (USD Billion)
  • Table 87 Mexico: Oral Transmucosal Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 88 Mexico: Oral Transmucosal Drugs Market, by Indication, 2019-2032 (USD Billion)
  • Table 89 Mexico: Oral Transmucosal Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 90 Argentina: Oral Transmucosal Drugs Market, by Product Distribution Channel, 2019-2032 (USD Billion)
  • Table 91 Argentina: Oral Transmucosal Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 92 Argentina: Oral Transmucosal Drugs Market, by Indication, 2019-2032 (USD Billion)
  • Table 93 Argentina: Oral Transmucosal Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 94 Middle East & Africa: Oral Transmucosal Drugs Market, by Product Distribution Channel, 2019-2032 (USD Billion)
  • Table 95 Middle East & Africa: Oral Transmucosal Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 96 Middle East & Africa: Oral Transmucosal Drugs Market, by Indication, 2019-2032 (USD Billion)
  • Table 97 Middle East & Africa: Oral Transmucosal Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 98 UAE: Oral Transmucosal Drugs Market, by Product Distribution Channel, 2019-2032 (USD Billion)
  • Table 99 UAE: Oral Transmucosal Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 100 UAE: Oral Transmucosal Drugs Market, by Indication, 2019-2032 (USD Billion)
  • Table 101 UAE: Oral Transmucosal Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 102 Saudi Arabia: Oral Transmucosal Drugs Market, by Product Distribution Channel, 2019-2032 (USD Billion)
  • Table 103 Saudi Arabia: Oral Transmucosal Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 104 Saudi Arabia: Oral Transmucosal Drugs Market, by Indication, 2019-2032 (USD Billion)
  • Table 105 Saudi Arabia: Oral Transmucosal Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 106 South Africa: Oral Transmucosal Drugs Market, by Product Distribution Channel, 2019-2032 (USD Billion)
  • Table 107 South Africa: Oral Transmucosal Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 108 South Africa: Oral Transmucosal Drugs Market, by Indication, 2019-2032 (USD Billion)
  • Table 109 South Africa: Oral Transmucosal Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 110 Israel: Oral Transmucosal Drugs Market, by Product Distribution Channel, 2019-2032 (USD Billion)
  • Table 111 Israel: Oral Transmucosal Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 112 Israel: Oral Transmucosal Drugs Market, by Indication, 2019-2032 (USD Billion)
  • Table 113 Israel: Oral Transmucosal Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)

List of Figures

  • Figure 1. Global Oral Transmucosal Drugs Market, 2019-2032 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Distribution Channel
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Product Distribution Channel
  • Figure 7. Global Oral Transmucosal Drugs Market, by Product Distribution Channel, 2021 & 2030 (USD Billion)
  • Figure 8. Market by Distribution Channel
  • Figure 9. Global Oral Transmucosal Drugs Market, by Distribution Channel, 2021 & 2030 (USD Billion)
  • Figure 10. Market by Route of Administration
  • Figure 11. Global Oral Transmucosal Drugs Market, by Route of Administration, 2021 & 2030 (USD Billion)
  • Figure 12. Market by Indication
  • Figure 13. Global Oral Transmucosal Drugs Market, by Indication, 2021 & 2030 (USD Billion)